CRNX
NASDAQ
$83.87
Crinetics Pharmaceuticals Inc (CRNX)
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for rare endocrine diseases and endocrine-related tumors. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $82.50 (-1.63%)
Market Cap
$8.84B
FCF 5Y CAGR
+43.02%
Free Cash Flow Yield
-4.75%
Beta (5Y)
1.02
Price Chart
Valuation
Market Cap$8.84B
P/S491.45
P/B6.92
Profitability
Total Revenue (TTM)$18M
Gross Profit (TTM)-$339M
EBITDA-$542M
Operating Margin-1308%
EPS-$5.10
Financial Health
Free Cash Flow Yield-4.75%
Growth & Risk
EPS 5Y CAGR+16.22%
FCF 5Y CAGR+43.02%
Beta (5Y)1.02
Sharpe Ratio1.19